Literature DB >> 16175573

Sequence analysis of the protein kinase gene family in human testicular germ-cell tumors of adolescents and adults.

Graham Bignell1, Raffaella Smith, Chris Hunter, Philip Stephens, Helen Davies, Chris Greenman, Jon Teague, Adam Butler, Sarah Edkins, Claire Stevens, Sarah O'Meara, Adrian Parker, Tim Avis, Syd Barthorpe, Lisa Brackenbury, Gemma Buck, Jody Clements, Jennifer Cole, Ed Dicks, Ken Edwards, Simon Forbes, Matthew Gorton, Kristian Gray, Kelly Halliday, Rachel Harrison, Katy Hills, Jonathon Hinton, David Jones, Vivienne Kosmidou, Ross Laman, Richard Lugg, Andrew Menzies, Janet Perry, Robert Petty, Keiran Raine, Rebecca Shepherd, Alexandra Small, Helen Solomon, Yvonne Stephens, Calli Tofts, Jennifer Varian, Anthony Webb, Sofie West, Sara Widaa, Andy Yates, Ad J M Gillis, Hans J Stoop, Ruud J H L M van Gurp, J Wolter Oosterhuis, Leendert H J Looijenga, P Andrew Futreal, Richard Wooster, Michael R Stratton.   

Abstract

The protein kinase gene family is the most frequently mutated in human cancer. Previous work has documented activating mutations in the KIT receptor tyrosine kinase in testicular germ-cell tumors (TGCT). To investigate further the potential role of mutated protein kinases in the development of TGCT and to characterize the prevalence and patterns of point mutations in these tumors, we have sequenced the coding exons and splice junctions of the annotated protein kinase family of 518 genes in a series of seven seminomas and six nonseminomas. Our results show a remarkably low mutation frequency, with only a single somatic point mutation, a K277E mutation in the STK10 gene, being identified in a total of more than 15 megabases of sequence analyzed. Sequencing of STK10 in an additional 40 TGCTs revealed no further mutations. Comparative genomic hybridization and LOH analysis using SNP arrays demonstrated that the 13 TGCTs mutationally screened through the 518 protein kinase genes were uniformly aneuploid with consistent chromosomal gains on 12p, 8q, 7, and X and losses on 13q, 18q, 11q, and 4q. Our results do not provide evidence for a mutated protein kinase implicated in the development of TGCT other than KIT. Moreover, they demonstrate that the general prevalence of point mutations in TGCT is low, in contrast to the high frequency of copy number changes. Copyright 2005 Wiley-Liss, Inc

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16175573      PMCID: PMC7212027          DOI: 10.1002/gcc.20265

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  15 in total

1.  High-resolution analysis of DNA copy number using oligonucleotide microarrays.

Authors:  Graham R Bignell; Jing Huang; Joel Greshock; Stephen Watt; Adam Butler; Sofie West; Mira Grigorova; Keith W Jones; Wen Wei; Michael R Stratton; P Andrew Futreal; Barbara Weber; Michael H Shapero; Richard Wooster
Journal:  Genome Res       Date:  2004-02       Impact factor: 9.043

2.  Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells.

Authors:  Friedemann Honecker; Hans Stoop; Ronald R de Krijger; Yun-Fai Chris Lau; Carsten Bokemeyer; Leendert H J Looijenga
Journal:  J Pathol       Date:  2004-07       Impact factor: 7.996

Review 3.  Genetics and biology of adult human male germ cell tumors.

Authors:  R S Chaganti; J Houldsworth
Journal:  Cancer Res       Date:  2000-03-15       Impact factor: 12.701

4.  Somatic mutations of the protein kinase gene family in human lung cancer.

Authors:  Helen Davies; Chris Hunter; Raffaella Smith; Philip Stephens; Chris Greenman; Graham Bignell; Jon Teague; Adam Butler; Sarah Edkins; Claire Stevens; Adrian Parker; Sarah O'Meara; Tim Avis; Syd Barthorpe; Lisa Brackenbury; Gemma Buck; Jody Clements; Jennifer Cole; Ed Dicks; Ken Edwards; Simon Forbes; Matthew Gorton; Kristian Gray; Kelly Halliday; Rachel Harrison; Katy Hills; Jonathon Hinton; David Jones; Vivienne Kosmidou; Ross Laman; Richard Lugg; Andrew Menzies; Janet Perry; Robert Petty; Keiran Raine; Rebecca Shepherd; Alexandra Small; Helen Solomon; Yvonne Stephens; Calli Tofts; Jennifer Varian; Anthony Webb; Sofie West; Sara Widaa; Andrew Yates; Francis Brasseur; Colin S Cooper; Adrienne M Flanagan; Anthony Green; Maggie Knowles; Suet Y Leung; Leendert H J Looijenga; Bruce Malkowicz; Marco A Pierotti; Bin T Teh; Siu T Yuen; Sunil R Lakhani; Douglas F Easton; Barbara L Weber; Peter Goldstraw; Andrew G Nicholson; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Cancer Res       Date:  2005-09-01       Impact factor: 12.701

5.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

Review 6.  Testicular germ-cell tumours in a broader perspective.

Authors:  J Wolter Oosterhuis; Leendert H J Looijenga
Journal:  Nat Rev Cancer       Date:  2005-03       Impact factor: 60.716

7.  Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours.

Authors:  B Köberle; J R Masters; J A Hartley; R D Wood
Journal:  Curr Biol       Date:  1999-03-11       Impact factor: 10.834

Review 8.  The Plk3-Cdc25 circuit.

Authors:  David L Myer; El Mustapha Bahassi; Peter J Stambrook
Journal:  Oncogene       Date:  2005-01-10       Impact factor: 9.867

9.  Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ-cell tumors.

Authors:  Leendert H J Looijenga; Hubert de Leeuw; Monique van Oorschot; Ruud J H L M van Gurp; Hans Stoop; Ad J M Gillis; Carlos A de Gouveia Brazao; Rob F A Weber; Wim J Kirkels; Thamar van Dijk; Marieke von Lindern; Peter Valk; Geczy Lajos; Edit Olah; Jahn M Nesland; Sophie D Fosså; J Wolter Oosterhuis
Journal:  Cancer Res       Date:  2003-11-15       Impact factor: 12.701

10.  KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors.

Authors:  Harri Sihto; Maarit Sarlomo-Rikala; Olli Tynninen; Minna Tanner; Leif C Andersson; Kaarle Franssila; Nina N Nupponen; Heikki Joensuu
Journal:  J Clin Oncol       Date:  2004-11-15       Impact factor: 44.544

View more
  33 in total

1.  Protein complex, gene, and regulatory modules in cancer heterogeneity.

Authors:  Nikolaos A Papanikolaou; Athanasios G Papavassiliou
Journal:  Mol Med       Date:  2008 Sep-Oct       Impact factor: 6.354

2.  An improved understanding of cancer genomics through massively parallel sequencing.

Authors:  Jamie K Teer
Journal:  Transl Cancer Res       Date:  2014-06       Impact factor: 1.241

3.  Identifying functional cancer-specific miRNA-mRNA interactions in testicular germ cell tumor.

Authors:  Nafiseh Sedaghat; Mahmood Fathy; Mohammad Hossein Modarressi; Ali Shojaie
Journal:  J Theor Biol       Date:  2016-05-25       Impact factor: 2.691

Review 4.  Human variation databases.

Authors:  Jan Küntzer; Daniela Eggle; Stefan Klostermann; Helmut Burtscher
Journal:  Database (Oxford)       Date:  2010-07-17       Impact factor: 3.451

Review 5.  Cancer driver mutations in protein kinase genes.

Authors:  Ali Torkamani; Gennady Verkhivker; Nicholas J Schork
Journal:  Cancer Lett       Date:  2008-12-10       Impact factor: 8.679

Review 6.  Genomic and proteomic biomarkers for cancer: a multitude of opportunities.

Authors:  Michael A Tainsky
Journal:  Biochim Biophys Acta       Date:  2009-05-04

7.  The Jeremiah Metzger Lecture: intelligent design of cancer therapy: trials and tribulations.

Authors:  James A Fagin
Journal:  Trans Am Clin Climatol Assoc       Date:  2007

Review 8.  Defining the blueprint of the cancer genome.

Authors:  Victor E Velculescu
Journal:  Carcinogenesis       Date:  2008-05-20       Impact factor: 4.944

9.  Caspase Cleavages of the Lymphocyte-oriented Kinase Prevent Ezrin, Radixin, and Moesin Phosphorylation during Apoptosis.

Authors:  Catherine Leroy; Natalya V Belkina; Thavy Long; Emeric Deruy; Colette Dissous; Stephen Shaw; David Tulasne
Journal:  J Biol Chem       Date:  2016-03-04       Impact factor: 5.157

10.  Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors.

Authors:  Anne Goriely; Ruth M S Hansen; Indira B Taylor; Inge A Olesen; Grete Krag Jacobsen; Simon J McGowan; Susanne P Pfeifer; Gilean A T McVean; Ewa Rajpert-De Meyts; Andrew O M Wilkie
Journal:  Nat Genet       Date:  2009-10-25       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.